Skip to main content

cancer diagnostics

By HIMSS TV | 09:45 am | February 23, 2026
Shlomi Madar, CEO of SpotitEarly, discusses the company's noninvasive test using a breath sample, which is analyzed by specially trained dogs capable of identifying unique cancer-related scent signatures combined with AI technology.
By Adam Ang | 04:55 am | November 05, 2025
Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.
By HIMSS TV | 07:00 am | August 27, 2024
Dr. Raghav Murali-Ganesh, cofounder and CEO of Osara Health, discusses the rise of cancer diagnosis thanks to diagnostic technologies and tools, advances in patient treatments and how Osara advances positive behavioral transformation.  
By Ahmed El Sherif | 10:42 am | June 28, 2021
Kheiron Medical Technologies will distribute its Mia, or “mammography intelligent assessment” in the GCC region via a new partnership with Atlas Medical.